Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-389545

AN2 Therapeutics, Inc. · ANTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 9, 2026
Accepted (ET)
Sep 11, 2026 · 7:45 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001880438

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF3,F4,F5Sep 9, 2026S523$6.0243D557,467ISee footnotes
Common StockF3,F4,F6Sep 9, 2026S585$6.0243D624,765ISee footnotes
Common Stockholding———9,077D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses